Moxie Self-Management and Education Support Program
NCT07280325
Brain Diseases, Cardiovascular Diseases
View Trial DetailsNCT Number: NCT07779928
This study aimed to develop and validate an innovative proprioceptive assessment instrument for the upper extremities, the PropArm-PosiMoF (PropArm). This observational study was conducted in three stages. The first stage focused on the development and validation of PropArm, including test-retest reliability, concurrent validity, and convergent validity. The second stage established age norms and cut-off points in healthy adults. In the final stage, PropArm was applied to patients with proprioceptive impairments (stroke, shoulder impingement syndrome, and diabetes mellitus patients) to examine its diagnostic accuracy and clinical applicability.
Trial opening soon.
Get Notified20 year–89 year
All sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Inclusion criteria
Exclusion criteria
Inclusion criteria
Exclusion criteria
Inclusion criteria
Exclusion criteria
Inclusion criteria
Exclusion criteria
Inclusion criteria
Diagnosis of diabetes is confirmed if any two of items (a-c) are met, or if any one of them remains positive on repeat testing; fulfillment of item (d) alone is also sufficient for diagnosis.
Exclusion criteria
Time frame: Baseline, within 2 weeks after Baseline
The instrument is designed to measure proprioception by recording position and force data. In the first stage, PropArm was conducted twice to examine the test-retest reliability of healthy young adults. In other stages, PropArm were collected once.
Time frame: Baseline
The instrument is designed to measure proprioception by recording position and force data. In the first stage, PropArm was conducted twice to examine the test-retest reliability of healthy young adults. In other stages, PropArm were collected once.
Time frame: Baseline
The instrument is designed to measure proprioception by recording position and force data. In the first stage, PropArm was conducted twice to examine the test-retest reliability of healthy young adults. In other stages, PropArm were collected once.
Time frame: Baseline
The instrument is designed to measure proprioception by recording position and force data. In the first stage, PropArm was conducted twice to examine the test-retest reliability of healthy young adults. In other stages, PropArm were collected once.
Time frame: Baseline
The instrument is designed to measure proprioception by recording position and force data. In the first stage, PropArm was conducted twice to examine the test-retest reliability of healthy young adults. In other stages, PropArm were collected once.
Time frame: Baseline, within 2 weeks after Baseline
The MicroFET3 is used to quantify the muscle power of elbow.
Time frame: Baseline
The MicroFET3 is used to quantify the muscle power of elbow.
Time frame: Baseline
The MicroFET3 is used to quantify the muscle power of elbow.
Time frame: Baseline
The MicroFET3 is used to quantify the muscle power of elbow
Time frame: Baseline
The MicroFET3 is used to quantify the muscle power of elbow.
Time frame: Baseline
VICON is used to capture the position data of limbs in space.
Time frame: Baseline, within 2 weeks after Baseline
The MTT-B is used to assess the ability to discriminate objects without vision (barognosis sense) of hand.
Time frame: Baseline
The MTT-B is used to assess the ability to discriminate objects without vision (barognosis sense) of hand.
Time frame: Baseline
The MTT-B is used to assess the ability to discriminate objects without vision (barognosis sense) of hand.
Time frame: Baseline
The MTT-B is used to assess the ability to discriminate objects without vision (barognosis sense) of hand.
Time frame: Baseline
The MTT-B is used to assess the ability to discriminate objects without vision (barognosis sense) of hand.
Time frame: Baseline
The CTT-C is a screening test used to exclude potential mild cognitive impairment patients.
Time frame: Baseline
The CTT-C is a screening test used to exclude potential mild cognitive impairment patients.
Time frame: Baseline
The CTT-C is a screening test used to exclude potential mild cognitive impairment patients.
Time frame: Baseline
The CTT-C is a screening test used to exclude potential mild cognitive impairment patients.
Time frame: Baseline
The FMA-UE is used to measure the motor function of affected hand in stroke patients.
Time frame: Baseline
The goniometer is used to measure the range of motion (ROM) of both sides of shoulders.
National Cheng-Kung University Hospital
Other
Development, Validation, and Clinical Application of an Innovative Proprioceptive Instrument for Upper Extremities: PropArm-PosiMoF (PropArm)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07280325
Brain Diseases, Cardiovascular Diseases
View Trial DetailsNCT07510919
Acute Ischemic Stroke, Brain Diseases
View Trial DetailsNCT06771024
Arthritis, Body Weight
Faro, Algarve, Portugal
View Trial DetailsNCT07151430
Arterial Occlusive Diseases, Arteriosclerosis
View Trial Details